Channing Capital Management LLC Buys 77,681 Shares of Integer Holdings Corporation $ITGR

Channing Capital Management LLC grew its stake in Integer Holdings Corporation (NYSE:ITGR) by 16.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 557,312 shares of the medical equipment provider’s stock after acquiring an additional 77,681 shares during the quarter. Channing Capital Management LLC owned 1.59% of Integer worth $57,587,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of ITGR. Alliancebernstein L.P. raised its position in shares of Integer by 885.1% in the 2nd quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock worth $136,016,000 after purchasing an additional 993,810 shares during the last quarter. Massachusetts Financial Services Co. MA bought a new stake in Integer during the 3rd quarter valued at about $41,938,000. Tributary Capital Management LLC raised its holdings in Integer by 92.6% in the third quarter. Tributary Capital Management LLC now owns 499,776 shares of the medical equipment provider’s stock worth $51,642,000 after buying an additional 240,226 shares during the last quarter. Millennium Management LLC raised its holdings in Integer by 2,408.8% in the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after buying an additional 118,224 shares during the last quarter. Finally, Viking Global Investors LP lifted its stake in shares of Integer by 9.1% in the second quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock worth $157,889,000 after buying an additional 106,692 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Stock Up 2.2%

Integer stock opened at $84.80 on Friday. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $136.06. The stock has a fifty day moving average of $82.83 and a 200 day moving average of $88.12. The company has a debt-to-equity ratio of 0.69, a quick ratio of 2.45 and a current ratio of 3.32. The stock has a market cap of $2.97 billion, a PE ratio of 29.55, a price-to-earnings-growth ratio of 0.77 and a beta of 0.77.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 EPS for the quarter, beating the consensus estimate of $1.70 by $0.06. The firm had revenue of $472.06 million during the quarter, compared to analyst estimates of $462.73 million. Integer had a net margin of 5.55% and a return on equity of 13.26%. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.43 EPS. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. As a group, sell-side analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer announced that its Board of Directors has initiated a share repurchase plan on Tuesday, November 4th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to reacquire up to 8.3% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.

Wall Street Analysts Forecast Growth

ITGR has been the subject of a number of recent analyst reports. Wall Street Zen lowered shares of Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Wells Fargo & Company lifted their target price on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday. Citigroup upped their price target on Integer from $75.00 to $92.00 and gave the company a “neutral” rating in a report on Friday. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Integer in a research report on Monday, December 29th. Finally, Truist Financial boosted their target price on Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday. Four equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $101.25.

More Integer News

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q4 results beat expectations — EPS $1.76 vs. $1.70 est and revenue $472.1M vs. $462.7M; full-year results showed 8% sales growth and strong adjusted EPS growth, supporting the company narrative of improving margins and growth execution. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Positive Sentiment: Truist raised its price target to $97 and kept a “buy” rating, signaling an analyst view of meaningful upside versus the current level. Benzinga — Truist raises target
• Neutral Sentiment: Wells Fargo also raised its target (to $84) but kept an “equal weight” rating — a modest signal that the stock is fairly valued near current levels rather than a clear endorsement. Benzinga — Wells Fargo raises target
• Neutral Sentiment: Full earnings materials (slide deck and call transcript) are available for deeper review of segment trends, backlog and margin drivers — useful for investors deciding if the beat is sustainable. Q4 Results – Earnings Call Presentation Q4 Earnings Call Transcript
• Negative Sentiment: Market reaction was mixed: some investors sold after management’s FY2026 guidance was viewed as softer than hoped, leading to an earlier pullback. Zacks notes shares fell despite the beat because guidance tempered enthusiasm. ITGR Shares Down Despite Q4 Earnings & Revenues Beat Estimates
• Negative Sentiment: Wider context: guidance midpoint and revenue outlook left some analysts noting modest downside risk versus certain targets, which could cap upside until visibility improves. MarketBeat — Earnings & Guidance Details

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.